Related Experiment Video
Updated: May 18, 2026

08:09
Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
Published on: March 24, 2017
Antibody selection and amino acid reversions
1School of Molecular and Biomedical Science, The University of Adelaide, Adelaide, South Australia 5005, Australia. jack.dasilva@adelaide.edu.au
Evolution; International Journal of Organic Evolution
|October 3, 2012
Summary
Pathogen adaptation to antibodies involves mutations that can impair protein function. This study shows that evolving antibody responses can reverse these mutations, leading to complex evolutionary dynamics.
Area of Science:
- Evolutionary biology
- Immunology
- Molecular biology
Background:
- Pathogens evade antibody surveillance via mutations in epitopes, which can incur a fitness cost.
- Antibody selection drives pathogen evolution, but the long-term consequences of this evolutionary pressure are complex.
Purpose of the Study:
- To investigate the hypothesis that evolving antibody responses can lead to the reversion of early escape mutations.
- To model the dynamics of molecular adaptation in pathogen populations under immune selection.
Main Methods:
- Stochastic simulation of molecular sequence evolution in finite populations.
- Analysis of allele fixation and reversion rates under varying selection and mutation pressures.
- Model validation using data from a human immunodeficiency virus type 1 (HIV-1) epitope.
Main Results:
- Allele fixation and amino acid reversion rates increased with population size and selection strength under strong selection and weak mutation.
- Increased mutation strength led to decreased adaptation rates due to clonal interference.
- The model accurately predicted reversion rates for an HIV-1 antibody epitope.
Conclusions:
- Antibody selection can drive complex adaptive evolutionary dynamics in pathogens.
- The interplay between immune selection, mutation, and population size shapes pathogen evolution.
- Understanding these dynamics is crucial for predicting pathogen adaptation and designing effective interventions.
More Related Videos
Related Concept Videos
Immunoprecipitation
Immunoprecipitation, or IP, is a widely used technique that employs protein-antibody interactions to isolate proteins or protein complexes in their native state for studying protein-protein interactions, quaternary structures, or supramolecular complexes. Various modifications of the technique, including chromatin IP, cross-linking IP, and fluorescence IP, are commonly used.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
Cross-reactivity
Overview
Diversity of Antigen Receptors
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Improving Translational Accuracy
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
Hybridoma Technology
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...

